Cargando…

A case–control study on the association of abdominal obesity and hypercholesterolemia with the risk of colorectal cancer

BACKGROUND: Obesity has frequently been associated with the dyslipidemic state and with the risk of various chronic diseases. OBJECTIVE: The objective of this study was to determine the relationship between obesity and blood lipids with a risk of colorectal cancer (CRC). METHODOLOGY: Histologically...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulaganathan, Vaidehi, Kandiah, Mirnalini, Shariff, Zalilah Mohd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166417/
https://www.ncbi.nlm.nih.gov/pubmed/30294246
http://dx.doi.org/10.4103/jcar.JCar_2_18
Descripción
Sumario:BACKGROUND: Obesity has frequently been associated with the dyslipidemic state and with the risk of various chronic diseases. OBJECTIVE: The objective of this study was to determine the relationship between obesity and blood lipids with a risk of colorectal cancer (CRC). METHODOLOGY: Histologically confirmed CRC patients from five local hospitals were matched with cancer-free controls for age, gender, and ethnicity (n = 140: 280). The study participants underwent physical assessment for the presence of obesity and 10 mL of fasting blood was drawn for blood lipid analysis. RESULTS: In this study, abdominal obesity significantly doubled the risk of CRC (adjusted odds ratio [AOR] =1.69, 95% confidence interval [CI] = 1–2.83). Hypercholesterolemia and low high-density lipoprotein cholesterol (HDL) increased the risk of CRC more than twofolds (AOR = 2.6, 95% CI = 1.7–3.9 and AOR = 3.8, 95% CI = 2.3–6.3, respectively). Abdominal obesity and hypercholesterolemia synergically doubled the risk of CRC (AOR = 2.0, 95% CI = 1–4). Low-HDL has shown no synergic association with other dyslipidemic states with an increased CRC risk. CONCLUSION: Improving abdominal obesity, hypercholesterolemia, and low HDL may be a clinically relevant strategy to reduce the risk of CRC among Malaysians.